V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20216879 | 20131217 | 0 | 72.3 | Palliative (P) | 2016-08-12 | 2016-08-31 | LANREOTIDE | 02 | N | LANREOTIDE | 101694691 |
| 20216880 | 20131218 | 0 | null | null | null | 2016-06-27 | null | 02 | null | DOXORUBICIN EMBOLISATION | 101329266 |
| 20216883 | 20131219 | 0 | 68.2 | null | 2017-03-06 | 2017-03-06 | LANREOTIDE | 02 | null | LANREOTIDE | 101863039 |
| 20216886 | 20131220 | 0 | null | null | 2016-12-30 | 2017-08-06 | FLUOROURACIL + MITOMYCIN | null | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101487291 |
| 20216887 | 20131221 | 0 | null | Palliative (P) | 2017-06-07 | 2017-07-05 | LANREOTIDE | 99 | N | LANREOTIDE | 101647133 |
| 20216893 | 20131222 | 0 | null | Palliative (P) | 2016-11-26 | 2016-12-31 | LANREOTIDE | 02 | N | LANREOTIDE | 100922473 |
| 20216901 | 20131223 | 0 | null | Palliative (P) | 2016-04-05 | 2016-04-05 | LANREOTIDE | 02 | N | LANREOTIDE | 101317856 |
| 20216905 | 20131224 | 0 | 47 | null | 2018-09-24 | 2018-10-01 | LANREOTIDE | 02 | null | LANREOTIDE | 101603517 |
| 20216908 | 20131225 | 0 | null | null | 2016-05-21 | 2016-05-21 | LANREOTIDE | 02 | null | LANREOTIDE | 100946681 |
| 20216916 | 20131226 | 0 | null | Palliative (P) | 2018-05-31 | 2018-06-03 | LANREOTIDE | 02 | N | LANREOTIDE | 101157076 |
| 20216918 | 20131227 | 0 | null | null | 2019-07-23 | 2019-11-30 | LANREOTIDE | 02 | null | LANREOTIDE | 100133658 |
| 20216921 | 20131228 | 0 | 89.2 | Palliative (P) | 2019-10-16 | 2019-11-16 | LANREOTIDE | 02 | N | LANREOTIDE | 101471933 |
| 20216924 | 20131229 | 0 | 88.4 | null | 2018-08-16 | 2018-08-23 | LANREOTIDE | 2 | null | LANREOTIDE | 100350929 |
| 20216931 | 20131230 | 0 | null | null | 2018-06-22 | 2018-11-12 | LANREOTIDE | N | null | LANREOTIDE | 100485390 |
| 20216933 | 20131231 | 0 | 76 | 03 | 2019-09-26 | 2019-09-26 | null | 02 | N | LENVATINIB | 101866015 |
| 20216937 | 20131232 | 0 | 50.4 | Palliative (P) | 2019-05-06 | 2019-05-12 | null | 02 | null | CAPECITABINE + MITOMYCIN | 100202544 |
| 20216941 | 20131233 | 0 | 83.85 | null | 2016-08-30 | 2016-09-13 | LANREOTIDE | 02 | null | LANREOTIDE | 100150606 |
| 20216942 | 20131234 | 0 | 67.5 | null | 2017-03-12 | 2018-02-02 | null | 02 | null | LANREOTIDE | 101075191 |
| 20216947 | 20131235 | 0 | 81.4 | null | 2019-08-20 | 2019-09-21 | null | 02 | null | LANREOTIDE | 101111928 |
| 20216953 | 20131236 | 0 | 87.7 | null | 2017-01-04 | 2017-07-30 | LANREOTIDE | 02 | null | LANREOTIDE | 101234667 |
| 20216963 | 20131237 | 0 | null | Palliative (P) | null | 2018-03-02 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101321834 |
| 20216964 | 20131238 | 0 | null | null | 2018-08-03 | 2018-11-22 | LANREOTIDE | 02 | null | LANREOTIDE | 101329221 |
| 20216965 | 20131239 | 0 | null | null | null | 2018-03-31 | LANREOTIDE | 02 | null | LANREOTIDE | 101527100 |
| 20216970 | 20131240 | 0 | null | Palliative (P) | 2019-04-06 | 2019-04-17 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100856677 |
| 20216972 | 20131241 | 0 | 59.4 | Palliative (P) | null | 2017-12-17 | null | 02 | N | CAPECITABINE + MITOMYCIN | 101280120 |
| 20216980 | 20131242 | 0 | 0 | null | 2017-02-27 | 2018-08-10 | CAPECITABINE + CISPLATIN + Trastuzumab | N | null | HCX | 101238088 |
| 20216981 | 20131243 | 0 | null | Palliative (P) | 2018-09-23 | 2018-10-12 | null | 02 | null | CAPECITABINE + MITOMYCIN | 100548524 |
| 20216982 | 20131244 | 0 | null | null | 2017-11-27 | 2017-12-05 | null | N | null | HCX | 101587114 |
| 20216984 | 20131245 | 0 | null | Palliative (P) | 2016-11-04 | 2016-12-17 | Cape+Cisplatin+Trastuzumab Main | 02 | N | HCX | 100724544 |
| 20216987 | 20131246 | 0 | 79.3 | Curative (C) | 2018-02-14 | 2018-02-21 | null | 02 | N | FLUOROURACIL + MITOMYCIN | 100702430 |
| 20216996 | 20131247 | 0 | 71.5 | null | null | 2018-06-02 | null | null | null | LENVATINIB | 101035183 |
| 20217002 | 20131248 | 0 | 0 | Palliative (P) | 2019-07-01 | 2019-11-30 | Capecitabine + Mitomycin | 02 | null | CAPECITABINE + MITOMYCIN | 101767869 |
| 20217006 | 20131249 | 0 | 64.2 | Palliative (P) | null | 2021-10-14 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100692643 |
| 20217011 | 20131250 | 0 | 68.2 | Palliative (P) | null | 2018-06-05 | null | 02 | N | CAPECITABINE + MITOMYCIN | 100818087 |
| 20217016 | 20131251 | 0 | 84.4 | Palliative (P) | null | 2018-08-20 | null | 02 | N | LENVATINIB | 101257095 |
| 20217027 | 20131252 | null | null | Neo-adjuvant (N) | null | 2017-10-23 | Doxorubicin chemoembolisation | null | Y | DOXORUBICIN EMBOLISATION | 100315900 |
| 20217032 | 20131253 | null | null | null | 2016-08-06 | 2016-08-26 | LENVATINIB | 02 | null | LENVATINIB | 101621951 |
| 20217034 | 20131254 | 1.59 | 78 | Palliative (P) | null | 2019-12-08 | HCX | 99 | N | HCX | 101086520 |
| 20217038 | 20131255 | 0 | null | Palliative (P) | 2020-10-05 | 2020-10-10 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 100176880 |
| 20217040 | 20131256 | 0 | 62 | Palliative (P) | 2017-11-04 | 2017-11-30 | null | null | N | HCX | 100592726 |
| 20217041 | 20131257 | 1.56 | 74.6 | Palliative (P) | null | 2020-05-19 | null | null | N | LENVATINIB | 101239860 |
| 20217048 | 20131258 | 0 | 64 | Palliative (P) | 2018-12-12 | 2018-12-23 | HCX (Cape + Cisp + Tras) - Load | N | N | HCX | 101367374 |
| 20217051 | 20131259 | 0 | null | null | 2018-08-19 | 2018-09-19 | null | 02 | null | HCX | 100477966 |
| 20217065 | 20131261 | 0 | 98.45 | Palliative (P) | 2018-09-17 | 2018-09-17 | Cape+Cisplatin+Trastuzumab Main | 2 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101733217 |
| 20217066 | 20131262 | 1.83 | null | null | 2016-07-09 | 2016-07-27 | LENVATINIB | 2 | null | LENVATINIB | 100789789 |
| 20217067 | 20131263 | 0 | null | null | null | 2017-09-29 | Cape+Cisplatin+Trastuzumab Main | 02 | null | HCX | 100618570 |
| 20217072 | 20131264 | 0 | null | null | null | 2019-05-06 | LANREOTIDE | 02 | null | LANREOTIDE | 100379273 |
| 20217085 | 20131265 | 0 | null | Palliative (P) | 2019-03-14 | 2019-06-05 | HCX (Cape + Cisp + Tras) - Load | 02 | N | HCX | 100263924 |
| 20217088 | 20131266 | 0 | 88.1 | null | 2016-09-17 | 2016-11-26 | LENVATINIB | 99 | null | LENVATINIB | 101664514 |
| 20217089 | 20131267 | 0 | null | Palliative (P) | 2015-07-01 | 2016-03-07 | null | 02 | N | HCX | 101870125 |